Percutaneous Interventions in Adults With CHD

Stopped early

Conditions studied: Congenital Disorders

In brief

The primary objective of this study is to determine the clinical benefits of percutaneous intervention to improve pulmonary blood flow on oxygen saturations, symptoms, exercise tolerance and hematocrit in patients with complex cyanotic congenital heart disease who are not candidates for surgical repair.

Key facts

Study ID

NCT00266916

Run by

Children's Healthcare of Atlanta

People needed

9

Starts

1996-01-01

Expected to finish

2006-08-01

Last updated by the study team

2007-05-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• greater than 18 years of age
• complex cyanotic heart disease
• oxygen saturation prior to intervention < 90%

You may not qualify if…

• those who do not meet inclusion criteria

Where it is running

• Children's Healthcare of Atlanta — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.